CO2021007863A2 - Vacuna conjugada polisacárido-proteína neumocócica multivalente - Google Patents

Vacuna conjugada polisacárido-proteína neumocócica multivalente

Info

Publication number
CO2021007863A2
CO2021007863A2 CONC2021/0007863A CO2021007863A CO2021007863A2 CO 2021007863 A2 CO2021007863 A2 CO 2021007863A2 CO 2021007863 A CO2021007863 A CO 2021007863A CO 2021007863 A2 CO2021007863 A2 CO 2021007863A2
Authority
CO
Colombia
Prior art keywords
protein conjugate
conjugate vaccine
pneumococcal polysaccharide
multivalent pneumococcal
polysaccharide
Prior art date
Application number
CONC2021/0007863A
Other languages
English (en)
Inventor
Rajendar Burki
Rajan Sriraman
Ramesh Venkat Matur
Narender Dev Mantena
Mahima Datla
Balamurali Masilamani
Vivek Babu Kandimalla
Veerapandu Sangareddy
Original Assignee
Biological E Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Biological E Ltd filed Critical Biological E Ltd
Publication of CO2021007863A2 publication Critical patent/CO2021007863A2/es

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K39/02Bacterial antigens
    • A61K39/09Lactobacillales, e.g. aerococcus, enterococcus, lactobacillus, lactococcus, streptococcus
    • A61K39/092Streptococcus
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K39/02Bacterial antigens
    • A61K39/09Lactobacillales, e.g. aerococcus, enterococcus, lactobacillus, lactococcus, streptococcus
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/62Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being a protein, peptide or polyamino acid
    • A61K47/64Drug-peptide, drug-protein or drug-polyamino acid conjugates, i.e. the modifying agent being a peptide, protein or polyamino acid which is covalently bonded or complexed to a therapeutically active agent
    • A61K47/6415Toxins or lectins, e.g. clostridial toxins or Pseudomonas exotoxins
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/62Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being a protein, peptide or polyamino acid
    • A61K47/64Drug-peptide, drug-protein or drug-polyamino acid conjugates, i.e. the modifying agent being a peptide, protein or polyamino acid which is covalently bonded or complexed to a therapeutically active agent
    • A61K47/646Drug-peptide, drug-protein or drug-polyamino acid conjugates, i.e. the modifying agent being a peptide, protein or polyamino acid which is covalently bonded or complexed to a therapeutically active agent the entire peptide or protein drug conjugate elicits an immune response, e.g. conjugate vaccines
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K2039/555Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55505Inorganic adjuvants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K2039/60Medicinal preparations containing antigens or antibodies characteristics by the carrier linked to the antigen
    • A61K2039/6031Proteins
    • A61K2039/6037Bacterial toxins, e.g. diphteria toxoid [DT], tetanus toxoid [TT]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K2039/60Medicinal preparations containing antigens or antibodies characteristics by the carrier linked to the antigen
    • A61K2039/6031Proteins
    • A61K2039/6068Other bacterial proteins, e.g. OMP
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K2039/70Multivalent vaccine

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Virology (AREA)
  • Communicable Diseases (AREA)
  • Toxicology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicinal Preparation (AREA)

Abstract

RESUMEN DE LA INVENCIÓN La presente invención se refiere a una composición de vacuna conjugada polisacárido-proteína neumocócica multivalente que comprende un polisacárido capsular neumocócico de uno o más serotipos de Streptococcus pneumoniae conjugados con una o más proteínas portadoras.
CONC2021/0007863A 2018-10-12 2021-06-16 Vacuna conjugada polisacárido-proteína neumocócica multivalente CO2021007863A2 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IN201841038835 2018-10-12
PCT/IN2019/050761 WO2020075201A1 (en) 2018-10-12 2019-10-11 Multivalent pneumococcal polysaccharide-protein conjugate vaccine

Publications (1)

Publication Number Publication Date
CO2021007863A2 true CO2021007863A2 (es) 2021-06-21

Family

ID=70164011

Family Applications (1)

Application Number Title Priority Date Filing Date
CONC2021/0007863A CO2021007863A2 (es) 2018-10-12 2021-06-16 Vacuna conjugada polisacárido-proteína neumocócica multivalente

Country Status (12)

Country Link
US (1) US20220143166A1 (es)
EP (1) EP3863667A4 (es)
JP (1) JP2022525492A (es)
CN (1) CN113194987A (es)
AU (1) AU2019358622A1 (es)
BR (1) BR112021012521A2 (es)
CA (1) CA3120926A1 (es)
CO (1) CO2021007863A2 (es)
EA (1) EA202191638A1 (es)
IL (1) IL284349A (es)
SG (1) SG11202106179VA (es)
WO (1) WO2020075201A1 (es)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP7369123B2 (ja) 2017-12-06 2023-10-25 メルク・シャープ・アンド・ドーム・エルエルシー 肺炎球菌多糖類-タンパク質コンジュゲートを含む組成物およびその使用方法
MA54533A (fr) 2018-12-19 2022-03-30 Merck Sharp & Dohme Compositions comprenant des conjugués polysaccharide-protéine de streptococcus pneumoniae et leurs méthodes d'utilisation
CN111588842A (zh) * 2020-05-06 2020-08-28 江苏金迪克生物技术股份有限公司 一种多价肺炎球菌多糖蛋白结合疫苗的制备方法
US20240133818A1 (en) * 2021-02-26 2024-04-25 Biological E Limited Activated-quenched polysaccharide and improved methods for quantification of polysaccharide in a vaccine composition

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102716480B (zh) * 2005-04-08 2023-03-21 惠氏有限责任公司 多价肺炎球菌多糖-蛋白质缀合物组合物
CN103656631B (zh) * 2012-09-24 2015-08-19 北京科兴中维生物技术有限公司 多价肺炎球菌荚膜多糖-蛋白缀合物组合物及其制备方法
CN107810010A (zh) * 2015-06-23 2018-03-16 生物E有限公司 多价肺炎球菌结合疫苗
UA126385C2 (uk) * 2016-09-30 2022-09-28 Байолоджикал І Лімітед Композиції полівалентної пневмококової вакцини, що містять кон'югати полісахарид-білок
CN108245674A (zh) * 2018-01-18 2018-07-06 北京智飞绿竹生物制药有限公司 一种多价肺炎球菌结合物组合疫苗的处方及其制备方法

Also Published As

Publication number Publication date
EP3863667A1 (en) 2021-08-18
CA3120926A1 (en) 2020-04-16
EP3863667A4 (en) 2022-08-17
CN113194987A (zh) 2021-07-30
JP2022525492A (ja) 2022-05-17
SG11202106179VA (en) 2021-07-29
AU2019358622A1 (en) 2021-06-17
EA202191638A1 (ru) 2021-12-27
IL284349A (en) 2021-08-31
BR112021012521A2 (pt) 2021-09-14
WO2020075201A1 (en) 2020-04-16
US20220143166A1 (en) 2022-05-12

Similar Documents

Publication Publication Date Title
MX2022014850A (es) Polisacaridos neumococicos y su uso en conjugados de polisacarido inmunogenico con proteina transportadora.
CO2021007863A2 (es) Vacuna conjugada polisacárido-proteína neumocócica multivalente
BR112020004471A8 (pt) Polissacarídeos pneumocócicos e uso dos mesmos em conjugados imunogênicos polissacarídeo-proteína carreadora
BR112020004509A8 (pt) Conjugado polissacarídeo-proteína carreadora, composição imunogênica compreendendo o mesmo e uso do referido conjugado
MX2022009928A (es) Polisacaridos neumococicos y su uso en conjugados de polisacarido inmunogenico con proteina transportadora.
CU24660B1 (es) Composiciones de vacunas multivalentes que comprenden conjugados de polisacárido-proteína de streptococcus pneumoniae utilizando proteínas portadoras psaa y crm197
NZ765694A (en) Compositions comprising streptococcus pneumoniae polysaccharide-protein conjugates and methods of use thereof
PE20161095A1 (es) Composiciones inmunogenicas que comprenden antigenos de sacaridos capsulares conjugados y uso de los mismos
EA201990126A1 (ru) Поливалентная пневмококковая полисахаридно-белковая конъюгатная композиция
BR112016016580A2 (pt) Polissacarídeos capsulares de streptococcus pneumoniae e conjugados dos mesmos
MX2018004939A (es) Vacuna.
BR112016015835A2 (pt) Polissacarídeos capsulares de streptococcus pneumoniae e conjugados destes
RS54349B1 (en) VACCINE CONTAINING STREPTOCOCCUS PNEUMONIAE Capsular POLYSACCHARIDE CONJUGATES
BR112021024393A8 (pt) Um conjugado de polissacarídeo-proteína pneumocócico de sorotipo 35b imunogênico e processo de conjugação para fabricar o mesmo
AR092897A1 (es) Composiciones inmunogenicas
MX2016003621A (es) Vacunas sinteticas libres de proteina y peptido contra streptococcus pneumoniae tipo 3.
PH12019500377A1 (en) Composition comprising multivalent capsular polysaccharide-transport protein and use thereof
AR117713A1 (es) Composiciones que comprenden conjugados de polisacárido de streptococcus pneumoniae con proteína y sus métodos de uso
CL2023002281A1 (es) Composición adyuvante de nanoemulsiones para vacunas neumocócicas conjugadas.
AR109377A1 (es) Composición conjugada neumocócica multivalente de polisacárido y proteína
AR093161A1 (es) Composicion de conjugados polisacarido-proteina neumococicos multivalente